The Association of Clinical Research Professionals

Clinical Researcher — August 2020

The August issue of Clinical Researcher ponders how we should go about “Rethinking Risk, Race, and Other Urgent Issues in Clinical Research,” and features articles and columns on risk-based management, patient diversity, remote and decentralized trials, and more.

Featured Articles

The Critical Need for Transparency and Disclosure of Participant Diversity in Clinical Trials

A Review of the FDA Process, Implementation, and Future Directions for the Approval of Electronic Nicotine Delivery Systems (ENDS)

Representation in Clinical Trials: A Review on Reaching Underrepresented Populations in Research

The Impact of COVID-19 on Clinical Trial Activities and the Research Environment

Risk-Based Clinical Trial Management: Harnessing the Transformation of RBM to RBQM

Also In This Issue…

The Urgency of Diversity

Clinical Research’s Carpe Diem Moment

The Centricity of Decentralizing Risk-Based Clinical Trials

What COVID-19 Teaches Us About Conducting Clinical Research Remotely and Electronically

Conducting Clinical Trials in the Era of COVID-19: The Challenges of Maintaining Patient Safety and Data Integrity

COVID-19 FDA Response: Guidance on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials

Treasuring Your Exceptions in Rare Disease Research

View Full Issue

View Other Issues